Startups
At GlySens®, we are dedicated to advancing the care of individuals with diabetes through the development of a long term, implantable continuous glucose monitoring technology.
Since the company’s inception in 1998, we have focused on designing and developing the world’s first truly long term, wireless, implantable, continuous glucose monitor, the Eclipse® ICGM® System. Our goal is to empower individuals with easy, at-a-glance, worry-free diabetes technologies that seamlessly deliver the information they need to optimize care, while freeing them to live life on their own terms.
CAUTION – Investigational Device. Limited by Federal law to investigational use.
Since the company’s inception in 1998, we have focused on designing and developing the world’s first truly long term, wireless, implantable, continuous glucose monitor, the Eclipse® ICGM® System. Our goal is to empower individuals with easy, at-a-glance, worry-free diabetes technologies that seamlessly deliver the information they need to optimize care, while freeing them to live life on their own terms.
CAUTION – Investigational Device. Limited by Federal law to investigational use.
Overview
Location
United States, California, San Diego
Employees
51-200
Total raised
$32M
Founded date
1998
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jan 6, 2015 | Series C round | $12M |
Mentions in press and media 16
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 5, 2016 | GlySens Closes $20M Series D Financing | GlySens Incorporated, a San Diego, California-based developer of long term continuous glucose monitoring system for people with diabetes, closed a $20M Series D financing. Backers included existing and new investors. The company intends to ... |
| Jan 5, 2016 | GlySens Picks Up $20M More For Glucose Monitoring | San Diego-based Glysens, a developer of continuous glucose monitoring systems, has picked up $20M in a Series D financing round. According to GlySens, the new round ccame from its prior investors from its Series C funding, plus additional n... |
| Aug 17, 2015 | Morning Read: FDA isn’t testing medical devices as much as they should, report says | — The Hill A LITTLE BIT EXTRA Jeff Bezos responded to The New York Times’ damning article depicting miserable working conditions at his online retail giant Amazon with a memo to staffers. The CEO urged employees to email him or human resour... |
| Feb 3, 2015 | West Health CEO on what kinds of healthcare cost-lowering startups he’s after | Valeriani says West Health’s more mission-driven than typical venture capital firms – that “the calculus to evaluate the effectiveness of our fund isn’t solely financial.” Returns are fed back into the West Health endowment, which funds the... |
| Jan 9, 2015 | Funding roundup - week ending 1/9/15 | Glassdoor, Wanda E-Commerce, NetDragon, Fitmob, Tookitaki, Frankly, X.ai, MUBI, Lalamove, Dato, Stem Seed stage Data intelligence start up Tookitaki raised $1 million in a seed funding round led by Jungle Ventures, along with Rebright Partn... |
| Jan 5, 2015 | GlySens Raises $12M in Series C Funding | GlySens, a San Diego, CA-based developer of continuous glucose monitoring systems for people with diabetes, raised $12m in Series C funding. Both new and returning investors participated in the round. The company intends to use the funds fo... |
| Jan 5, 2015 | GlySens Raises $12M For Diabetes Monitoring | San Diego-based GlySens said today that it has raised $12M in a Series C funding round, for the company's continuous glucose monitoring systems for people with diabetes. The company said the funding came from both new and returning investor... |
| Apr 2, 2014 | No more needles: Startup tests implant that can measure blood sugar for up to a year | The crucial difference is that the sensors in the existing systems need to be re-calibrated several times a day and can only stay in place for a week at most. Leading vendor DexCom, for example, states that its G4 Platinum is “the only sens... |
| Mar 27, 2014 | An interactive physical therapy tool attracts $7.5M from West Health Fund | The investment in the San Diego-based company, is designed to help the company ramp up its engineering, product development and customer support teams. It will also help finance additional research studies. A research study with the Center ... |
Show more
Reviews 0
FAQ about GlySens Incorporated
When was GlySens Incorporated founded?
GlySens Incorporated was founded in 1998.
How much funding has GlySens Incorporated raised?
GlySens Incorporated has raised $32M in total across 2 funding rounds.
What funding rounds has GlySens Incorporated raised?
Parsers VC lists 2 funding rounds of GlySens Incorporated, among them a Series C round of $12M on Jan 6, 2015.
What has the press written about GlySens Incorporated?
Parsers VC has collected 16 articles mentioning GlySens Incorporated, among them “GlySens Closes $20M Series D Financing” (Jan 5, 2016) and “GlySens Picks Up $20M More For Glucose Monitoring” (Jan 5, 2016).
Is GlySens Incorporated still active?
Yes, GlySens Incorporated is active; its latest activity on Parsers VC dates from Jan 5, 2016.